Intercept Pharmaceuticals Inc (NASDAQ:ICPT)
| 18.57 Delayed Data As of May 27 |  +1.17 / +6.72%Today’s Change | 11.60 Today|||52-Week Range 22.36 | +14.00% Year-to-Date |
Latest ICPT News | Press Releases
| Pfizer (PFE) Gets Fast Track Designation for NASH Therapy May 27 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 17.40 |
| Today’s open | 17.40 |
| Day’s range | 17.27 - 18.65 |
| Volume | 707,056 |
| Average volume (3 months) | 946,900 |
| Market cap | $518.2M |
Data as of 05/27/2022
Growth & Valuation
| Earnings growth (last year) | +65.62% |
| Earnings growth (this year) | +0.35% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +16.24% |
| P/E ratio | -- |
| Price/Sales | 1.43 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ARCTArcturus Therapeutic... | +4.16 | +25.05% |
| KNSAKiniksa Pharmaceutic... | +0.16 | +2.02% |
| COLLCollegium Pharmaceut... | +0.40 | +2.57% |
| --Basilea Pharmaceutic... | 0.00 | 0.00% |
Data as of 4:00pm ET, 05/27/2022
Financials
| Next reporting date | August 3, 2022 |
| EPS forecast (this quarter) | -$0.03 |
| Annual revenue (last year) | $363.5M |
| Annual profit (last year) | -$91.4M |
| Net profit margin | -25.15% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Morristown, New Jersey |
Forecasts
